MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 39 filers reported holding MERUS N V in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,182,000 | -66.1% | 59,000 | -61.7% | 0.51% | -73.8% |
| Q2 2022 | $3,487,000 | -44.0% | 154,000 | -34.6% | 1.94% | -33.2% |
| Q1 2022 | $6,227,000 | -16.9% | 235,500 | 0.0% | 2.91% | -7.6% |
| Q4 2021 | $7,489,000 | +179.0% | 235,500 | +93.0% | 3.15% | +232.4% |
| Q3 2021 | $2,684,000 | -63.7% | 122,000 | -73.5% | 0.95% | -55.7% |
| Q2 2020 | $7,401,000 | +499.8% | 460,000 | +564.0% | 2.14% | +140.0% |
| Q3 2019 | $1,234,000 | – | 69,274 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
| COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
| MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
| Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
| BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
| TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
| Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |